About DF/HCC

Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community. Five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health—combined their scientific strengths to create a rich, collaborative environment that transcends institutional borders. DF/HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973.

Today, more than 1,100 DF/HCC cancer researchers are working together in innovative clinical-, translational-, basic-, and population-based research programs. Our members receive in excess of $600 million in cancer research funding. Cost-effective shared facilities, or centralized core laboratories, enable access to cutting edge technologies and allow us to build world-class scientific archives. Thousands of patients are being enrolled in our clinical trials. Our members are training and educating the next generation of cancer researchers.

As one of the largest cancer research enterprises in the world, DF/HCC is committed to maximizing the impact of its research for cancer patients and ultimately realizing a world without cancer.

Breast Cancer

Cancer Data Sciences

Cancer Care Delivery Research

Cancer Cell Biology

Cancer Epidemiology

Cancer Genetics

Cancer Immunology

Cancer Risk and Disparities


Gastrointestinal Malignancies

Gynecologic Cancers

Kidney Cancer


Lung Cancer

Lymphoma and Myeloma


Prostate Cancer

Developmental Therapeutics


Drew Memmott

Associate Director for Administration (617) 632-3488 EMAIL
Amanda Smith Executive Assistant to Drew Memmott (617) 632-3487 EMAIL
Mary Lombard DF/HCC Administrative Specialist (617) 632-6198 EMAIL


Brenda Mulligan Communications Director (617) 632-4015 EMAIL
Richard Oakley Online Communications Specialist (617) 632-4276 EMAIL

Core Facilities

Michelle Cox Senior Director for Core Facilities (617) 632-3566 EMAIL
Rachel Goldblatt Program Manager (617) 632-2587 EMAIL


Thomas Leonard Web Systems Architect (617) 632-3937 EMAIL

Initiative to Eliminate Cancer Disparities

Karen Burns White Director (617) 632-3244 EMAIL

Membership, Program Coordination, and Operations

Deborah Goff Deputy Associate Director for Program and Operations Support (617) 632-4044 EMAIL
Jackie Hwang Program Manager (617) 632-5685 EMAIL
Erica Fletcher Grant Administrator (617) 632-4864 EMAIL

For clinical trials administration contact information, visit the Clinical Research section.